Discontinuation of primary and secondary prophylaxis for opportunistic infections in HIV-Infected Patients Who Had CD4+ Cell Count <200 cells/mm3 but Undetectable Plasma HIV-1 RNA: An Open-Label Randomized Controlled Trial

• Main Authors: Chaiwarith R., Praparattanapan J., Nuntachit N., Kotarathitithum W., Supparatpinyo K.
• Format: Article
• Language: English
• Published: 2014
• Online Access: http://www.scopus.com/inward/record.url?eid=2-s2.0-84873335200&partnerID=40&md5=257528313279ad41a2c0943209059bab; http://cmuir.cmu.ac.th/handle/6653943832/4035
• Institution: Chiang Mai University

The CDC recommends discontinuing opportunistic infections (OIs) prophylaxis in HIV-infected patients who have CD4+ cell count >200 cells/mm3 after receiving combination antiretroviral therapy (cART). A prospective randomized controlled trial was conducted at Chiang Mai University Hospital fro...